INR:8972. betboss 365 Sanofi sold $13 billion worth of Regeneron shares, and the latter directly repurchased $5 billion! 20 batches of drugs from 10 pharmaceutical co ...

Suzhou Hongsen Pharmaceutical's $1 billion asthma drug "Salbuterol Sulfate Solutio ...

A new study recently published in Psychophysiology has used machine learning to identify brain structures and networks ...

The aim of SENS-501 (OTOF-GT) is to restore hearing by introducing a functional copy of the OTOF gene directly into hair cells via viral vector technology (AAV). This therapy aims to restore the ...

Gene Therapy to Target GD2 for Oncology is under clinical development by Bristol-Myers Squibb and currently in Phase I for Osteosarcoma.

Technological Advancements : Ongoing innovations in gene delivery methods, such as the development of next-generation viral and non-viral vectors, are expected to drive substantial growth in the gene ...

GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will ...

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope ...

Physician-researchers with City of Hope have developed a way to add features to T cells to help them overcome mechanisms of ...

Integrated gene therapy successfully treated Haemophilia A in India, providing long-term relief without bleeding episodes for ...

Physician-researchers with City of Hope ®, one of the largest cancer research and treatment organizations in the United States with its National Medical Center named Top 5 in the nation for cancer by ...